Sera Prognostics announces publication of PRIME study findings for preterm birth.

Sera Prognostics has announced that the findings of the PRIME study, one of the largest studies on preterm birth, have been accepted for publication in a peer-reviewed journal. The study's abstract data was previously presented at the Society for Maternal-Fetal Medicine's annual meeting. The PRIME study aims to improve maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients.